Merck & Co (MRK)
60.09
-0.16 -0.27%
NYSE
Apr 24, 20:00
Delayed 2m
USD
Merck & Co Shareholders Equity (Quarterly):
34.34B for Dec. 31, 2017View 4,000+ financial data types
Browse...
View Full Chart
Merck & Co Shareholders Equity (Quarterly) Chart
Export Data
Save Image
Print Image
For advanced charting, view our full-featured
Fundamental Chart
Merck & Co Historical Shareholders Equity (Quarterly) Data
View and export this data going back to 1984.
Start your Free Trial
Export Data
Date Range:
| Data for this Date Range | |
|---|---|
| Dec. 31, 2017 | 34.34B |
| Sept. 30, 2017 | 38.25B |
| June 30, 2017 | 39.46B |
| March 31, 2017 | 39.84B |
| Dec. 31, 2016 | 40.09B |
| Sept. 30, 2016 | 43.74B |
| June 30, 2016 | 43.36B |
| March 31, 2016 | 43.81B |
| Dec. 31, 2015 | 44.68B |
| Sept. 30, 2015 | 45.59B |
| June 30, 2015 | 46.45B |
| March 31, 2015 | 47.76B |
| Dec. 31, 2014 | 48.65B |
| Sept. 30, 2014 | 45.22B |
| June 30, 2014 | 48.36B |
| March 31, 2014 | 49.98B |
| Dec. 31, 2013 | 49.76B |
| Sept. 30, 2013 | 47.42B |
| June 30, 2013 | 47.50B |
| March 31, 2013 | 53.03B |
| Dec. 31, 2012 | 53.02B |
| Sept. 30, 2012 | 55.75B |
| June 30, 2012 | 55.19B |
| March 31, 2012 | 54.86B |
| Dec. 31, 2011 | 54.52B |
| Sept. 30, 2011 | 55.14B |
| June 30, 2011 | 55.50B |
| March 31, 2011 | 54.38B |
| Dec. 31, 2010 | 54.38B |
| Sept. 30, 2010 | 55.59B |
| June 30, 2010 | 55.23B |
| March 31, 2010 | 57.88B |
| Dec. 31, 2009 | 59.06B |
| Sept. 30, 2009 | 22.91B |
| June 30, 2009 | 20.32B |
| March 31, 2009 | 19.56B |
| Dec. 31, 2008 | 18.76B |
| Sept. 30, 2008 | 19.57B |
| June 30, 2008 | 20.26B |
| March 31, 2008 | 19.52B |
| Dec. 31, 2007 | 18.18B |
| Sept. 30, 2007 | 20.72B |
| June 30, 2007 | 19.47B |
| March 31, 2007 | 18.48B |
| Dec. 31, 2006 | 17.56B |
| Sept. 30, 2006 | 19.29B |
| June 30, 2006 | 19.30B |
| March 31, 2006 | 18.85B |
| Dec. 31, 2005 | 17.98B |
| Sept. 30, 2005 | 17.78B |
There is no data for the selected date range.
An error occurred. Please try again by refreshing your browser or contact us with details of your problem.
About Shareholders' Equity
Shareholders' equity is difference between a company's total assets and total liabilities. Also referred to as stockholders' equity, net worth, or net assets.
Learn More
Advertisement
MRK Shareholders Equity (Quarterly) Benchmarks
| Benchmarks | |
|---|---|
| Abbott Laboratories | 30.90B |
| Bristol-Myers Squibb | 11.74B |
| Celgene | 6.921B |
MRK Shareholders Equity (Quarterly) Range, Past 5 Years
| Minimum | 34.34B | Dec 2017 |
| Maximum | 49.98B | Mar 2014 |
| Average | 44.43B |
MRK Shareholders Equity (Quarterly) Excel Add-In Codes
- Metric Code: shareholders_equity
- Latest data point: =YCP("MRK", "shareholders_equity")
- Last 5 data points: =YCS("MRK", "shareholders_equity", -4)
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
MRK News
Merck Suspends Study Of Pembrolizumab in Bladder Cancer Treatment Following Safety Committee Meeting
MT Newswires 04/24 14:22 ET
MT Newswires 04/24 14:22 ET
Early-stage study of Keytruda/radiotherapy combo in bladder cancer suspended
SA Breaking News 04/24 11:15 ET
SA Breaking News 04/24 11:15 ET
EMA accepts Merck's marketing application for Keytruda for first-line lung cancer
SA Breaking News 04/23 16:59 ET
SA Breaking News 04/23 16:59 ET
Analyst Actions: Goldman Sachs Upgrades Merck & Company to Conviction Buy from Neutral
MT Newswires 04/23 08:29 ET
MT Newswires 04/23 08:29 ET
Advertisement
